← Leaderboards
Colin Fred Greineder
University Of Michigan At Ann Arbor
$2,818,848
Attributed
$5,721,338
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,721,338 · 4
By mechanism
R01$5,056,274 · 3
K08$665,064 · 1
Top collaborators
- Peter M Tessier5 shared
- Geoffrey Douglas Barnes3 shared
- Shawna Nicole Smith3 shared
- Megan M Weivoda1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Peter M Tessier$7,601,443
- Helena H Ritchie$2,309,029
- David Berrey Kershaw$2,472,569
- Laurel L. Northouse$5,558,442
- Mark E Meyerhoff$16,191,724
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposSafetyPathway InteractionsPharmaceutical PreparationsAnimal ModelAffectDoseMouse ModelTargeted TreatmentProteinsGenerationsPreventEndotheliumMediatingFunctional DisorderSiteReceptorMortalityImproved OutcomeAccident And Emergency DepartmentInterestUnited StatesLifeAmerican
Grant awards (14)
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$774,699
R01 · FY2025 · HL
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease$735,235
R01 · FY2025 · AG
Optimizing bone surface targeting of therapeutic antibodies for osteoporosis$465,663
R01 · FY2025 · AR · contact PI
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease$94,262
R01 · FY2025 · AG
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$763,210
R01 · FY2024 · HL
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease$762,048
R01 · FY2024 · AG
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease$31,422
R01 · FY2024 · AG
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease$721,526
R01 · FY2023 · AG
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$708,209
R01 · FY2023 · HL
ICAM-1 targeted thrombomodulin: an experimental therapeutic for the Acute Respiratory Distress Syndrome$132,300
K08 · FY2020 · HL · contact PI
ICAM-1 targeted thrombomodulin: an experimental therapeutic for the Acute Respiratory Distress Syndrome$132,300
K08 · FY2019 · HL · contact PI
ICAM-1 targeted thrombomodulin: an experimental therapeutic for the Acute Respiratory Distress Syndrome$132,300
K08 · FY2018 · HL · contact PI
ICAM-1 targeted thrombomodulin: an experimental therapeutic for the Acute Respiratory Distress Syndrome$134,082
K08 · FY2017 · HL · contact PI
ICAM-1 targeted thrombomodulin: an experimental therapeutic for the Acute Respiratory Distress Syndrome$134,082
K08 · FY2016 · HL · contact PI